Geron Historical Financial Ratios
| GERN Stock | USD 4.17 0.11 2.71% |
Geron is recently reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 2.86 or Days Sales Outstanding of 2.7 K will help investors to properly organize and evaluate Geron financial condition quickly.
Geron |
About Geron Financial Ratios Analysis
GeronFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Geron investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Geron financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Geron history.
Geron Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Geron stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Geron sales, a figure that is much harder to manipulate than other Geron multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Asset Turnover
The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.Most ratios from Geron's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Geron current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.At this time, Geron's Capex To Revenue is very stable compared to the past year.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 461.95 | 1.9K | 2.5K | 2.7K | PTB Ratio | 3.16 | 11.52 | 4.86 | 2.86 |
Geron fundamentals Correlations
Click cells to compare fundamentals
Geron Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Geron fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 562.21 | 1.7K | 286.94 | 1.5K | 5.1K | 5.3K | |
| Ptb Ratio | 1.91 | 2.05 | 3.16 | 11.52 | 4.86 | 2.86 | |
| Days Sales Outstanding | 636.37 | 1.0K | 461.95 | 1.9K | 2.5K | 2.7K | |
| Book Value Per Share | 0.71 | 0.78 | 0.39 | 0.21 | 0.43 | 0.41 | |
| Stock Based Compensation To Revenue | 13.22 | 27.25 | 5.8 | 13.42 | 81.66 | 85.75 | |
| Pb Ratio | 1.91 | 2.05 | 3.16 | 11.52 | 4.86 | 2.86 | |
| Ev To Sales | 537.52 | 1.8K | 301.39 | 1.5K | 5.1K | 5.4K | |
| Roic | (0.5) | (0.33) | (0.67) | (1.05) | (0.59) | (0.62) | |
| Inventory Turnover | (63.93) | (69.32) | (0.56) | (0.28) | (0.32) | (0.33) | |
| Net Income Per Share | (0.15) | (0.33) | (0.28) | (0.37) | (0.32) | (0.34) | |
| Days Of Inventory On Hand | (5.71) | (5.27) | (652.15) | (1.3K) | (1.5K) | (1.4K) | |
| Payables Turnover | 43.41 | 7.23 | 0.12 | 0.0852 | 20.08 | 11.16 | |
| Sales General And Administrative To Revenue | 45.42 | 101.49 | 21.3 | 73.2 | 291.71 | 306.29 | |
| Research And Ddevelopement To Revenue | 113.2 | 203.51 | 61.54 | 160.27 | 527.62 | 554.0 | |
| Capex To Revenue | 0.9 | 1.58 | 0.15 | 0.72 | 3.5 | 3.68 | |
| Cash Per Share | 0.6 | 0.93 | 0.73 | 0.56 | 0.45 | 0.58 | |
| Pocfratio | (5.9) | (6.48) | (4.18) | (7.23) | (7.18) | (7.54) | |
| Capex To Operating Cash Flow | (0.009423) | (0.006016) | (0.002166) | (0.003384) | (0.004948) | (0.005195) | |
| Pfcf Ratio | (5.85) | (6.44) | (4.17) | (7.21) | (7.14) | (7.5) | |
| Days Payables Outstanding | 8.41 | 50.46 | 3.1K | 4.3K | 18.17 | 17.26 | |
| Roe | (0.47) | (0.36) | (0.96) | (1.76) | (0.74) | (0.78) | |
| Ev To Operating Cash Flow | (5.64) | (6.77) | (4.39) | (7.22) | (7.27) | (7.64) | |
| Pe Ratio | (6.53) | (4.07) | (5.71) | (3.3) | (6.54) | (6.21) | |
| Return On Tangible Assets | (0.38) | (0.28) | (0.54) | (0.74) | (0.47) | (0.49) | |
| Ev To Free Cash Flow | (5.59) | (6.73) | (4.38) | (7.2) | (7.24) | (7.6) | |
| Earnings Yield | (0.0974) | (0.15) | (0.25) | (0.18) | (0.3) | (0.16) | |
| Current Ratio | 5.03 | 6.46 | 4.11 | 2.35 | 3.16 | 3.0 | |
| Tangible Book Value Per Share | 0.71 | 0.78 | 0.39 | 0.21 | 0.43 | 0.41 | |
| Receivables Turnover | 0.91 | 0.57 | 0.35 | 0.79 | 0.19 | 0.14 | |
| Graham Number | 1.6 | 1.86 | 2.31 | 2.21 | 1.32 | 1.69 | |
| Shareholders Equity Per Share | 0.71 | 0.78 | 0.39 | 0.21 | 0.43 | 0.41 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.33) | Revenue Per Share 0.047 | Quarterly Revenue Growth 171.384 | Return On Assets (0.30) | Return On Equity (0.69) |
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.